These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1702687)

  • 21. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1974 Jan; 112(1):392-7. PubMed ID: 4130152
    [No Abstract]   [Full Text] [Related]  

  • 22. Cleavage of myelin basic protein by acid-soluble neutral proteases of delipidated white matter.
    Berlet HH; Ilzenhöfer H; Meyer A
    Prog Clin Biol Res; 1984; 146():243-8. PubMed ID: 6201895
    [No Abstract]   [Full Text] [Related]  

  • 23. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
    Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
    Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic protein from central nervous system myelin.
    Hashim GA
    Prog Clin Biol Res; 1980; 49():79-122. PubMed ID: 6163164
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibody reaction to basic myelin proteins after intracisternal administration into animals].
    Mendzheritskiĭ AM
    Vopr Med Khim; 1984; 30(5):106-10. PubMed ID: 6084891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple encephalitogenic peptides of myelin basic protein in A.CA mice.
    Rajan AJ; Cross AH; Raine CS; Diamond B
    Cell Immunol; 1993 Apr; 147(2):378-87. PubMed ID: 7680964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis.
    Stoll G; Müller S; Schmidt B; van der Meide P; Jung S; Toyka KV; Hartung HP
    Am J Pathol; 1993 Jun; 142(6):1866-75. PubMed ID: 7685153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful immunocytochemical localization of myelin components in paraffin sections of human nervous tissue with preliminary observations on multiple sclerosis and metachromatic leukodystrophy lesions.
    Itoyama Y; Sternberger N; Quarles R; Webster HD; Richardson EP; Cohen S; Moser HW
    Trans Am Neurol Assoc; 1978; 103():216-9. PubMed ID: 92845
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of lipid histochemistry data in experimental allergic encephalitis and multiple sclerosis.
    Petrescu A; Anghelescu N
    Neurol Psychiatr (Bucur); 1979; 17(1):61-6. PubMed ID: 441663
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomic and proteomic analysis of multiple sclerosis. Opinion.
    Robinson WH; Utz PJ; Steinman L
    Curr Opin Immunol; 2003 Dec; 15(6):660-7. PubMed ID: 14630200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of myelin basic protein in neurology].
    Fang J
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):595-7. PubMed ID: 1702687
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.